Sigrun E. Einarsdottir

Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications

A tale of two trials: A father-daughter perspective on the bureaucracy of clinical trials in Europe.

A tale of two trials: A father-daughter perspective on the bureaucracy of clinical trials in Europe.

Journal: European journal of internal medicine
Published: August 07, 2026

Safety and outcomes of CD19 CAR-T cell therapy in splenectomized patients with B-cell lymphomas.

Safety and outcomes of CD19 CAR-T cell therapy in splenectomized patients with B-cell lymphomas.

Journal: Transplantation and cellular therapy
Published: April 24, 2026

Impact of ASTCT Toxicity Grading System on Outcomes After CAR-T for Mature B-Cell Malignancies.

Impact of ASTCT Toxicity Grading System on Outcomes After CAR-T for Mature B-Cell Malignancies.

Journal: Transplantation and cellular therapy
Published: March 04, 2026

Impact of ASTCT toxicity grading system on outcomes after CAR-T for mature B-cell malignancies.

Impact of ASTCT toxicity grading system on outcomes after CAR-T for mature B-cell malignancies.

Journal: Transplantation and cellular therapy
Published: March 04, 2026

Outcomes of Salvage Therapy after Early-Line CD19 Chimeric Antigen Receptor T-Cell Failure in Large B-Cell Lymphoma.

Outcomes of Salvage Therapy after Early-Line CD19 Chimeric Antigen Receptor T-Cell Failure in Large B-Cell Lymphoma.

Journal: Transplantation and cellular therapy
Published: February 02, 2026

Outcomes of Salvage Therapy after Early-Line CD19 Chimeric Antigen Receptor T-Cell Failure in Large B-Cell Lymphoma.

Outcomes of Salvage Therapy after Early-Line CD19 Chimeric Antigen Receptor T-Cell Failure in Large B-Cell Lymphoma.

Journal: Transplantation and cellular therapy
Published: February 02, 2026

Beyond Antibodies: Influenza Vaccine Induced T-Cell Response in Hematological Malignancy- Commentary on Insights From Hall et al.

Beyond Antibodies: Influenza Vaccine Induced T-Cell Response in Hematological Malignancy- Commentary on Insights From Hall et al.

Journal: The Journal of infectious diseases
Published: January 17, 2026

Beyond Antibodies: Influenza vaccine induced T-Cell-Response in Hematological Malignancy.

Beyond Antibodies: Influenza vaccine induced T-Cell-Response in Hematological Malignancy.

Journal: The Journal of infectious diseases
Published: January 17, 2026

Antigen-specific T-cell responses to SARS-CoV-2 vaccination after hematopoietic cell transplant or CAR T-cell therapy.

Antigen-specific T-cell responses to SARS-CoV-2 vaccination after hematopoietic cell transplant or CAR T-cell therapy.

Journal: Blood advances
Published: January 07, 2026

Antigen-specific T cell responses to SARS-CoV-2 vaccination after Hematopoietic Cell Transplant or CAR T cell Therapy.

Antigen-specific T cell responses to SARS-CoV-2 vaccination after Hematopoietic Cell Transplant or CAR T cell Therapy.

Journal: Blood advances
Published: January 07, 2026

Tumor CD19 Expression Determines Distinct Clinical Outcomes After CD19 CAR T-Cell Therapy in Large B-Cell Lymphoma.

Tumor CD19 Expression Determines Distinct Clinical Outcomes After CD19 CAR T-Cell Therapy in Large B-Cell Lymphoma.

Journal: Blood cancer discovery
Published: January 04, 2026

Sexual Activity During Neutropenia and Immunosuppression: What Do You Tell Your Patient?

Sexual Activity During Neutropenia and Immunosuppression: What Do You Tell Your Patient?

Journal: JCO oncology practice
Published: December 01, 2025
Showing 1-12 of 49

Last Updated: 09/26/2026